![Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation](https://oncodaily.com/pub/uploads/2023/11/IMG_4080-e1698949873408-1280x925.jpeg)
Photo from Emanuele Ammatuna/LinkedIn
Nov 4, 2023, 00:28
Emanuele Ammatuna: Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation
Emanuele Ammatuna, Hematologist at University Medical Center Groningen, shared on LinkedIn:
“Time to reconsider 3+7 for older patients fit for allogenic stem cell transplantation. The addition of a bcl-2 inhibitor to HMA should be the next investigation in this category of patients.”
Source: Emanuele Ammatuna/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023